- 暫無數據
繁体中文
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
A team of computer and electrical engineers at UC Santa Barbara, in collaboration with several colleagues at Caltech and another colleague at Anello Photonics, has developed a first-of-its-kind chip that can carry both laser and photonic waveguides. In a paper published in the journal Nature, the team describes how they made the chip and how it worked during testing.With the advent of integrated c...
On quartz sheets, the angular rhombic boron nitride crystals with a thickness of only 1 to 3 microns are as thin as cicada wings, but their energy efficiency is 100 to 10000 times higher than traditional optical crystals. At the opening ceremony of the 2024 Zhongguancun Forum Annual Conference held on April 25th, the world's thinnest known optical crystal was listed as one of the top ten technolog...
Researchers have made breakthrough discoveries in the field of nanophotonics. They have successfully developed a locked mode ultrafast laser using lithium niobium, a material known for its excellent optical properties. This breakthrough opens up new possibilities for revolutionary applications, including telecommunications, data storage, and ultra fast imaging.A mode-locked laser is a type of lase...
Recently, Zhang Xin's research team from the Institute of Oceanography, Chinese Academy of Sciences, based on the in-situ laser Raman spectroscopy technology, made new progress in the in-situ recognition and quantification of methane carbon isotopes by using the significant differences in the Raman spectra of methane carbon isotopes (13CH4 and 12CH4). The relevant results were recently published i...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...